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Background Left ventricular (LV) volumetric and functional parameters measured with cardiac computed tomography (cardiac CT)
augment risk prediction and discrimination for future mortality. Gender- and age-specific standard values for LV
dimensions and systolic function obtained by 64-slice cardiac CT are lacking.
Methods
and results
1155 patients from the Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter
registry (54.5% males, mean age 53.1+ 12.4 years, range: 18–92 years) without known coronary artery disease
(CAD), structural heart disease, diabetes, or hypertension who underwent cardiac CT for various indications were
categorized according to age and sex. A cardiac CT data acquisition protocol was used that allowed volumetric meas-
uring of LV function. Image interpretation was performed at each site. Patients with significant CAD (.50% stenosis) on
cardiac CT were excluded from the analysis. Overall, mean left ventricular ejection fraction (LVEF) was higher in
women when compared with men (66.6+ 7.7% vs. 64.6+ 8.1%, P, 0.001). This gender-difference in overall LVEF
was caused by a significantly higher LVEF in women ≥70 years when compared with men ≥70 years
(69.95+ 8.89% vs. 65.50+ 9.42%, P ¼ 0.004). Accordingly, a significant increase in LVEF was observed with age
(P ¼ 0.005 for males and P, 0.001 for females), which was more pronounced in females (5.21%) than in males
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(2.6%). LV end-diastolic volume decreased in females from 122.48+27.87 (,40 years) to 95.56+23.17 (.70 years;
P, 0.001) and in males from 155.22+35.07 (,40 years) to 130.26+27.18 (.70 years; P, 0.001).
Conclusion Our findings indicate that the LV undergoes a lifelong remodelling and highlight the need for age and gender adjusted
reference values.
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Introduction
Left ventricular (LV) function and diameters are important predic-
tors of morbidity and mortality in various cardiovascular diseases.
Cardiac computed tomography (cardiac CT) has proved high accur-
acy and reproducibility in the evaluation of LV morphology and func-
tion, and cardiac CT measures of left ventricular ejection fraction
(LVEF) have recently been shown to improve risk stratification
and discrimination for future cardiac events in patients with coron-
ary artery disease (CAD).1 – 3 Thus, given the widespread use of
high-resolution cardiac CT for non-invasive evaluation of CAD
and the incremental prognostic value of concomitant assessment
of cardiac function, accurate determination of LV parameters
obtained by cardiac CT is fundamental for risk stratification and
appropriate decision making in CAD.
Starting from the observation that women with heart failure
present with a clinical profile different from that of men and that
women show poorer cardiovascular outcomes compared with
males, the varied predisposition to LV dysfunction between men
and women came recently into light.4,5 Indeed, the risk of cardiovas-
cular events has been shown to start at higher LVEF indices in
women when compared with men, indicating that thresholds to
pathologic state are gender dependent.6 In addition, in view of the
continuously growing elderly population in most countries, it
becomes increasingly important to distinguish normal age-related
changes in LV size and function from pathologic findings. However,
despite growing awareness of gender- and age-related differences in
diagnostic approaches, gender- and age-specific standard values for
LV dimensions and systolic function obtained by 64-slice cardiac CT
are lacking. Indeed, inconsistent data derived from small populations
have been reported, indicating that LVEF decreases or remains
unchanged with age and is not influenced by gender.7,8 Knowledge
of these parameters, however, is crucial in order to stratify risk and
guide therapy of patients with CAD. Thus, given the prognostic
importance of LV function and its routine use in clinical decision
making, the aim of this study was to assess age- and gender-specific
changes of LV dimensions and systolic function by 64-slice cardiac
CT in a large international multicenter cohort.
Methods
Study population
1155 patients (54.5% males, mean age 53.1+12.4 years, range: 18–92)
from the CONFIRM (Coronary CT Angiography EvaluatioN For Clinical
Outcomes: an InteRnational Multicenter Registry) registry who
underwent gated cardiac CT with quantitative LV measurements for
evaluation of possible CAD were included in the present analysis.
CONFIRM, an international, multicenter, observational cohort study,
prospectively enrolled 27 170 consecutive patients .18 years of age
between 2005 and 2009 who underwent least 64-detector row cardiac
CT for suspected CAD at 12 centers in 6 countries (Canada, Germany,
Italy, Korea, Switzerland, and the USA). Details of the CONFIRM regis-
try design and data elements have been described previously.9 – 12
Among 27 125 patients, those free of previously diagnosed CAD,
structural heart disease including cardiomyopathies, diabetes, hyperten-
sion, or ventricular hypertrophy was included in the present analysis.
Information on the presence or absence of these conditions was pro-
spectively collected in each individual. Patients whose cardiac CT images
revealed obstructive CAD (.50% luminal narrowing), structural heart
disease, or patients with incomplete data on LV function and studies
with technical problems were excluded. Patients with non-obstructive
CAD (,50% luminal narrowing) were not excluded from the study.
Therefore, 1155 remaining individuals were included for the final
analyses. The following risk factors for CAD were systematically deter-
mined: dyslipidaemia, family history of premature CAD, smoking, and
obesity. Patients were neither included nor excluded on the basis
of quantitative analysis of global LV function from the gated cardiac
CT images. Five age groups by decade were established for both
genders: ≤40 years, between .40 and ≤50 years,.50 and ≤60 years,
.60 and ,70 years, and ≥70 years. The study complies with the
Declaration of Helsinki and patient consent or a waiver of informed con-
sent (as per recommendations of each institutional review board) was
obtained at each site in keeping with sites-specific regulations.
Data acquisition, image reconstruction, and
cardiac CT analysis
Cardiac CT scanners used in the CONFIRM registry and data acquisition
for cardiac CT have been previously described.9 For coronary artery
analysis, each site performed per-segment analysis for individual coron-
ary artery segments by using a 16-segment model. CAD was defined as
the presence of any plaque. Coronary atherosclerotic lesions were
quantified for lumen diameter stenosis by visual estimation and graded
as none (0% luminal stenosis), mild (1–49%), moderate (50–69%), or
severe (.70%). A coronary lesion compromising the lumen by
.50% was defined as obstructive. All patients were in normal sinus
rhythm and were capable of the breath hold needed for cardiac CT.
Patients with heart rates .70 beats/min were given oral or intravenous
metoprolol as per local site protocol. During cardiac CT 80–140 mL of
iodinated contrast material was used and timing of contrast material
administration was chosen to optimize uniform contrast enhancement
of the coronary arteries. Scanning parameters were as follows: collima-
tion, 64 × 0.625/0.750 mm; tube voltage, 100 or 120 mV; effective
400–650 mA; gantry rotation time/2, 83–350 ms. Dose reduction
strategies were used when available. Multiphase reconstructions were
performed for each dataset and based on these datasets, multiplanar
reconstructions permitting assessment of LV function were created.
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LVEF was measured volumetrically (excluding papillary muscles) with
post-processing by using 10–20 phases of the cardiac cycle (temporal
resolution, 83–175 ms).13 LVEF was automatically calculated using end-
diastolic (EDV) and end-systolic (ESV) volumes. Indexed values were
obtained by normalizing EDV and ESV to body surface area (BSA). Image
interpretation was uniformly performed at each site according to
Society of Cardiovascular Computed Tomography guidelines by level
III-qualified readers with .3 years of experience in cardiac CT image
interpretation.14
Statistical analysis
STATA version 14 (StataCorp LP, College Station, TX, USA) was used
for all statistical analyses. Categorical variables are presented as frequen-
cies and continuous variables as mean+ SD or median+ interquartile
range (IQR). Variables were compared with x2 statistic for categorical
variables and by Student’s unpaired t-test, Mann–Whitney non-
parametric test or median comparison test where appropriate for
continuous variables. LVEF and LV volumes are indicated as
model-estimated marginal means and SD. Differences in between strati-
fied age groups for both genders were calculated using ANOVA post hoc
tests. Normality of the data was assessed with the Kolmogorov–Smir-
nov test. LV volumes and LVEF were not normally distributed, and con-
sequently, 95% confidence interval was used to define the limit of
normality. General linear model analysis was performed to model the
data, construct the reference range as mean and 95% CI, and assess
the influence of age and gender on LV volumes and LVEF. Spearman
or Pearson correlation coefficient was used to quantify relations. To de-
termine whether our findings were independent of confounders, multi-
variable linear regression was performed (dependent variable LVEF,
independent variables EDV, gender and age, covariates BMI). A two-
tailed P-value of 0.05 was considered statistically significant.
Results
Patient characteristics
A total of 1155 subjects (629 (54.5%) males) without obstructive
CAD as determined by cardiac CT were analysed. The demographic
characteristics of the study population are listed in Table 1. Patients
had been referred for cardiac CT for evaluation of chest pain or
dyspnoea. Our study population included 19% obese subjects
(body mass index [BMI] .30 kg/m2), while patients with diabetes
or hypertension were excluded from our analysis. Mean age
of our study population was 54.3+ 12.2 years for women
and 52.1+ 12.5 years for men (P ¼ 0.001 for men vs. women).
Age range was 18–87 years for women and 18–92 years for men.
Our study population was normally distributed according to age
(Figure 1A), thus, very young and very old patients comprised the
smallest subgroups and were therefore summarized in patients
,40 years and patients .70 years, respectively. Women were
more often symptomatic (P, 0.001) and suffered less often from
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Characteristics of study population
Parameters (n 5 1155) Females (n 5 526) Males (n 5 629) P-value
Age (years, mean+ SD) 54.3+12.2 52.1+12.5 0.001
BMI all (kg/m2, mean+ SD) (1142) 26.1+5.8 26.9+4.4 ,0.001
≥30 kg/m2, n (%) (1142) 106 (20.5) 116 (18.6) 0.41
BSA (m2, mean+ SD) (1142) 1.7+0.2 2.0+0.2 ,0.001
Current smoker, n (%) 69 (13.1) 91 (14.5) 0.51
FHx of CAD, n (%) (1147) 205 (39.2) 212 (34.0) 0.07
Dyslipidaemia, n (%) (1153) 192 (36.6) 256 (40.8) 0.15
Chest pain (1137) ,0.001
Asymptomatic, n (%) 207 (40.4) 357 (57.1)
Non-anginal chest pain, n (%) 119 (23.2) 93 (14.9)
Atypical chest pain, n (%) 107 (20.9) 118 (18.9)
Typical chest pain, n (%) 79 (15.4) 57 (9.1)
Shortness of breath, n (%) 161 (30.6) 133 (21.1) ,0.001
Ethnicity (376)
Caucasian n (%) 154 (86.5) 152 (76.8) 0.02
Agatston calcium score, median, IQR (763) 33.7+119.7 (0, 0–10) 90.4+230.0 (1, 0–57) ,0.001
Small heart (ESV ,20 mL), n (%) 23 (4.4) 4 (0.6) ,0.001
Pretest CAD likelihood (1135) ,0.001
Low (≤10%) 302 (59.2) 250 (40.0)
Intermediate (11–89%) 181 (35.5) 344 (55.0)
High (≥90%) 27 (5.3) 31 (5.0)
Level of CAD (1152) ,0.001
Normal 345 (65.8) 312 (49.7)
Non-obstructive (1–49%) 179 (34.2) 316 (50.3)
BMI, body mass index; BSA, body surface area; FHx, family history; CAD, coronary artery disease; ESV, end-systolic volume; IQR, interquartile range.
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dyslipidaemia than men (P ¼ 0.15) (Table 1). Women had a lower
BMI and a lower BSA than men (P, 0.001, Table 1). Older male
patients had a significantly lower BMI when compared with younger
male patients (P, 0.001 for ,40 years vs. ≥70 years), while
no significant difference in BMI was observed between older
and younger females (P ¼ 0.7 for ,40 years vs. ≥70, Table 2).
Mean Agatston calcium score was lower in women than in men
(33.7+ 119.7 vs. 90.4+ 230.0, P, 0.001, Table 1). Subjects were
classified into six age groups: group 1 consisted of 149 subjects
(54 women) aged ,40 years, group 2 consisted of 315 subjects
(127 women) aged 40–49 years, group 3 consisted of 361 sub-
jects (183 women) aged 50–59 years, group 4 consisted of 205 sub-
jects (99 women) aged 60–69 years, group 5 consisted of 125
subjects (63 women) aged ≥70 years (Table 2).
Influence of age and sex on LVEF
Mean LVEF for women (n ¼ 526) was higher (66.6+7.7%) than for
men (64.6+ 8.1%, n ¼ 629; P, 0.001, Figure 1B and C ). When
subjects were stratified into age subgroups based on age in decades,
a significant difference between sexes for LVEF in the age groups
.70 years was seen, while no statistically significant difference
between sexes was found for LVEF in subjects under 70 years of
age (Figure 2A, Table 2). In addition, a strong and positive correlation
of age and LVEF was found in females while a weaker correlation
was observed in males (females: Pearson r ¼ 0.2, P, 0.001; males:
Pearson r ¼ 0.1; P ¼ 0.005; Figure 3A). Accordingly, a significant
difference was seen between females ≥70 years and females ,40
years (P ¼ 0.001), but not in males (P ¼ 0.09). Of note, when
LVEF in women past menopausal age (51.4 years15) was compared
with women at premenopausal age, a significant higher LVEF was
found in those past menopausal age when compared with women
below premenopausal age (P, 0.001). Multivariable regression
analysis with LVEF being the dependent variable showed
that age showed a stronger association with LVEF in females
(B-coefficient ¼ 0.05, P, 0.001) than in males (B-coefficient ¼
0.01, P, 0.001). In addition, the gender by age interaction term
Figure 1 (A) Histograms of age distribution. Histogram showing distribution of LVEF for females (B) and males (C).
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was significantly associated with LVEF (P ¼ 0.044), while only age
(P, 0.001) but not gender (P ¼ 0.1) was a statistically significant
main effect variable for LVEF, indicating that gender and age show
not a simple linear association with LVEF (Table 3). While BMI
was not found to have significant independent influence on LVEF
(P ¼ 0.9), LVESV, and LVEDV both correlated significantly with
LVEF (P, 0.001, Table 3), indicating that concomitant changes in
both, LVESV and LVEDV, trigger the observed changes in LVEF
with increasing age.
Influence of age on LV volumes
Men had significantly higher absolute and indexed LVEDV and
LVESV values than women. This difference was more pronounced
in older age groups (Figure 2B and C, Table 2). When LVESV was
stratified by both gender and age, categorizing age in 10-year inter-
vals, LVESV decreased with age in females from 44.4+ 17.2 mL
(,40 years) to 29.9+14.0 mL (≥70 years; P, 0.001) and in males
from 57.2+ 20.0 mL (,40 years) to 45.3+ 16.7 mL (≥70 years;
P, 0.001) (Figure 2, Table 2). Accordingly, a significant negative
association was found between age and LV volumes in both sexes;
however, a stronger association between age and LV volumes
was observed in women (Pearson r ¼ 20.4, P, 0.001 for LVESV
and r ¼ 20.7, P, 0.001 for LVEDV, Figure 3B and C ) than in men
(Pearson r ¼ 20.3, P, 0.001 for LVESV and r ¼ 20.6, P ¼ 0.005
for LVEDV, Figure 3B and C ). As the ageing process per se is asso-
ciated with a decrease in body size and since an association between
an increase in BSA and an increase in chamber dimensions has been
reported, we corrected chamber volumes for body size. Compared
with uncorrected values, normalization of LV volumes (LVEDV/BSA
and LVESV/BSA) cancelled out the significant difference in LV
volumes between genders seen in younger age groups (,50 years,
Table 2). In contrast, indexing for BSA did not change the gender-
difference in older age groups (Table 2). As expected, women had
smaller hearts than men (defined as ESV, 20 mL; 4.4% in females
vs. 0.6% in males; P, 0.001, Table 1). The percentage of female
patients with a small heart was higher in older age groups (1.9%
for ,40 year group, 15.9% for ≥70 year group; P ¼ 0.01, Table 2).
Multivariable regression analysis showed that age and gender were
significant variables for LVEDV (P, 0.001 for age and P ¼ 0.04 for
gender), while only age (P, 0.001) but not gender was significantly
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Gender-related differences in different age groups in LVEF and left ventricular volumes
Age
<40 40–49 50–59 60–69 ≥70
Variable Males
N ¼ 629 95 188 178 106 62
LVEF (%) 62.9+8.0 63.8+7.1 65.3+7.6 66.2+9.3 65.5+9.4
EDV (mL) 155.2+35.1 144.33+29.61 142.28+34.37 135.54+34.73 130.26+27.18
ESV (mL) 57.2+20.0 53.03+17.14 49.67+18.65 46.75+19.09 45.34+16.69
EDV/BSA (mL/m2) 74.9+14.6 71.13+13.37 71.43+16.04 68.02+16.39 67.69+14.54
ESV/BSA (mL/m2) 27.6+9.1 26.20+8.19 24.90+8.87 23.34+9.04 23.65+9.21
Small heart (%) 0 0 3 (1.69) 1 (1.94) 0
BMI (kg/m2) 27.8+4.8 27.77+4.39 26.46+4.70 26.37+3.56 25.31+2.89
Variable Females
N ¼ 526 54 127 183 99 63
LVEF (%) 64.7+7.0 65.3+7.5 66.3+7.3 68.0+7.4 70.0+8.9
EDV (mL) 122.5+27.9 124.0+26.2 116.5+24.0 107.2+23.8 95.6+23.2
ESV (mL) 44.4+17.2 43.2+15.9 39.5+13.7 34.3+12.9 29.9+14.0
EDV/BSA (mL/m2) 71.5+14.6 69.4+13.0 66.1+12.4 63.1+12.0 58.3+13.2
ESV/BSA (mL/m2) 26.1+9.9 24.4+9.2 22.3+7.2 20.2+7.4 18.4+8.6
Small heart (%) 1 (1.85) 0 6 (3.3) 6 (6.1) 10 (15.9)
BMI (kg/m2) 25.3+6.7 26.5+5.6 27.1+6.5 25.4+4.5 24.7+4.5
P-values for men vs. women at each age group
LVEF (%) 0.21 0.08 0.17 0.10 0.004
EDV (mL) ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
ESV (mL) ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
EDV/BSA (mL/m2) 0.08 0.15 ,0.001 0.007 0.001
ESV/BSA (mL/m2) 0.11 0.02 0.002 0.006 0.001
Small heart (%) 0.36 – 0.50 0.058 0.001
BMI (kg/m2) ,0.001 0.002 0.89 0.019 0.20
A small heart was defined as ESV ,20 mL. Values are all given as mean+ SD.
EDV, end-diastolic volume; ESV, end-systolic volume; EDV/BSA, EDV adjusted for BSA; ESV/BSA, ESV adjusted for BSA; BMI, body mass index.
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associated with LVESV indicating that gender differences in LVEDV
might trigger the observed differences in LVEF between elderly men
and women.
Reference limits for LVEF
LVEF in our study population was not normally distributed, thus the
95% confidence limit was used to define cut-offs for abnormality.
Given the marked gender differences in mean LVEF measurements,
men and women were separated for these analyses. Mean LVEF was
66.65 (95% CI: 65.96–67.34) in women and 64.65 (95% CI: 64.03–
65.27) in men. Table 4 indicates mean and 95% confidence intervals
of LVEF for each age group. For better visualization of the data,
linear regression was applied to model the data (Figure 4). In patients
≥70 years, there was no overlap between the limits of the bootstrap
95% CI for women and men (63.26–67.74% for men, 67.84–72.06%
for women, Table 4), indicating that different normal limits should be
used for older women and men.
Discussion
We report here LVEF values obtained by cardiac CT in a large
population free of hypertension, diabetes, structural heart disease,
and obstructive CAD. Our findings indicate that women have a high-
er cut off value for normal LVEF than men due to smaller ventricular
Figure 2 (A) Comparison of LVEF. Data are presented as estimated mean+95% CI. *P, 0.05 (male vs. female). (B) Comparison of LVESV.
Data are presented as estimated mean+ 95% CI. *P, 0.05 (male vs. female). (C ) Comparison of LVEDV. Data are presented as estimated
mean+95% CI. *P, 0.05 (male vs. female).
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Figure 3 (A) Regression lines and scatter plots of relationship between LVEF and age in males and females. (B) Regression lines and scatter plots
of relationship between LVESV and age in males and females. (C) Regression lines and scatter plots of relationship between LVEDV and age in
males and females. SEE, standard error of estimates.
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Table 3 Data output of multivariable regression
analysis and test for interaction among independent
variables (EDV, ESV, gender, and age)
Dependent variable:
LVEF
Mean SD B-coefficient P-value
Independent variable
Age 53.1 12.4 0.05 ,0.001
Male gender – – 1.65 0.114
LVESV 45.4 18.2 20.59 ,0.001
LVEDV 129.8 33.3 0.20 ,0.001
Covariable: BMI 26.6 5.1 0.02 0.854
Interaction:
Age × gender
– – 20.04 0.044
BMI was tested as covariate. Values are all given as mean+ SD.
LVEF, left ventricular ejection fraction; EDV, end-diastolic volume; ESV, end-systolic
volume.
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Table 4 Lower and upper limits of bootstrap (500
reps) 95% CI of the mean of LVEF based on gender and
age
Age LVEF (%)
Males Females
95% CI 95% CI
Lower Upper Lower Upper
,40 61.33 64.48 62.95 66.53
40–49 62.82 64.80 64.05 66.61
50–59 64.17 66.33 65.30 67.22
60–69 64.43 67.91 66.59 69.41
≥70 63.26 67.74 67.84 72.06
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volumes and that LVEF increases with age in both genders. These
age-dependent alterations are more pronounced in women than
in men, indicating that age- and gender-adjusted LVEF reference
values are needed.
Assessment of LV function and volumes is the cornerstone of
cardiac diagnostics and numerous studies have highlighted its prog-
nostic value in patients with CAD.16–18 Heart failure is the most fre-
quent complication observed in patients with CAD and while more
men than women suffer from heart failure at younger ages, at the age
of 75 the reverse is true.19,20 Notably, heart failure is frequently un-
derdiagnosed and established late in female patients,21 – 23 which
could be linked with the fact that the risk of cardiovascular events
starts at higher LVEF indices in women when compared with
men.6 Thus, distinguishing impaired LV function from normal age-
and gender-related changes is crucial, since the difference between
these measurements may be the difference between whether a pa-
tient does, or does not, qualify for therapeutic intervention. During
the last decade, cardiac CT has proved to provide excellent diagnos-
tic information for the analysis of LV function and an additive prog-
nostic value of cardiac CT-measured LV function was recently
demonstrated.24 Taking into account that modern cardiac CT
equipment implements now permit to acquire cardiac CT datasets
with a submillisievert fraction of effective radiation dose and given
that LV measurements by cardiac CT show a high agreement with
those obtained by other imaging modalities including echocardiog-
raphy and cardiac magnetic resonance (CMR) imaging, cardiac CT
offers a reliable alternative to assess LV function in patients with
CAD.25–27
There is strong evidence showing that LV function is associated
with traditional risk factors including diabetes mellitus, hyperten-
sion, smoking, and dyslipidaemia. Indeed, diabetes mellitus is consid-
ered a major contributor to the development of heart failure, even
in the absence of CAD and hypertension,28 while blood pressure is
one of the most dominant variables predicting LV hypertrophy, thus,
patients with diabetes mellitus and/or hypertension were excluded
from the present analysis.29 Smoking has been associated with
decreased regional LV function in asymptomatic individuals30 and
dyslipidaemia has been shown to have an adverse effect on LV per-
formance in patients with CAD.31,32 Similarly, obesity has been
found to be associated with increased LV mass and decreased LV
volumes.33 While no differences were detected regarding the preva-
lence of dyslipidaemia and smoking between males and females in
our study, we observed that women had a lower BMI than men,
and a significant decrease in BMI with increasing age was seen in
males but not in females. However, BMI was not found to have
significant independent influence on LVEF in our study, thus, the
observed gender-specific changes in LV systolic function occurring
with advancing age do not seem to depend on an increase in BMI.
In addition, it is known that coronary artery calcification (CAC) is
associated with the incidence of congestive heart failure and a
correlation between CAC and LV diastolic dysfunction has recently
been observed in elderly people.34 Of note, in our study, males had
significantly higher calcium scores than female subjects. However,
considering the overall low calcium scores in our study population
(33.7 in females and 90.3 in males) and given that an association
between CAC and diastolic dysfunction was only observed in
patients with high calcium scores .400,34 it seems unlikely that
CAC was a predictor of age-dependent LV remodelling in our popu-
lation. Since our study was underpowered to assess the impact of
CAC on LV function and volumes, further prospective studies will
have to evaluate how CAC affects LV volumes in males and females
at different ages.
Among the hypothesized mechanisms accounting for the
stronger positive correlation between age and LVEF in women
when compared with men, age-dependent changes in oestrogen/
testosterone status are notable, as are gender-based lifestyle factors
or differences in neurohumoral signalling. In fact, progressive myo-
cyte loss occurring with increasing age in men but not in women was
observed in an autopsy study and may explain why women show a
stronger positive correlation between age and LVEF than men.35
Figure 4 Age-adjusted values for LVEF for males and females. Linear regression was applied to model the data, which are presented as mean and
95% confidence intervals.
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Reduced testosterone levels and reduced physical activity in older
men have been suggested to account for the enhanced myocyte
apoptosis in elderly men.8,35 Of note, while strong and negative cor-
relations were found between age and LV volumes, the association
between age and LVEF was much weaker, which further supports
the notion that an extraneous variable, e.g. changes in LV mass
and/or increased afterload, might influence age-dependent changes
of the LV. However, data on myocardial mass and aortic compliance
were not collected in our cohort, thus, we are unable to determine
whether the higher LVEF in aged women was secondary to differ-
ences in contractile state or loading conditions. Interestingly, with
increasing age, a higher prevalence of small hearts was detected in
our female study population (n ¼ 1 at age ,40 years and n ¼ 6 at
age .70 years). Since we observed a correlation between LVESV
and LVEF, it is likely that the augmented LVEF in elderly women is
partially based upon women having smaller hearts than men which,
in turn, raises the question whether the observed alterations of LV
function in elderly women have a protective or detrimental impact
on cardiovascular morbidity and mortality. Indeed, the differential
predisposition to functional cardiac impairment in men and women
at different ages is not yet understood, and, although heart failure is
less common in women, overall mortality in females is higher.36,37
Along that line, one could hypothesize that elderly women live
under constant hyperdynamic conditions to compensate for the dis-
advantage of smaller ventricles and that the latter may predispose
them to enhanced cardiac vulnerability in high-stress situations.
Indeed, women have higher baseline sympathetic activity and exces-
sive sympathetic discharge after acute myocardial infarction (MI) and
during heart failure than men,38,39 and lower testosterone levels in
elderly men have been associated with decreased cardiac sympa-
thetic nerve activity.40 Of note, pathological cardiac conditions
associated with sympathetic hyperactivity such as Takotsubo
syndrome or cardiac syndrome X are highly prevalent in postmeno-
pausal women.41,42 However, whether higher regional cardiac
sympathetic activity drives the adaption for a heart of smaller dimen-
sions in elderly women warrants further investigation.
There are limitations to this study that should be pointed out.
First, our study has the inherent limitations of an open-label, obser-
vational registry, including intersite variability in image acquisition
and analysis. However, image interpretation was uniformly per-
formed at all CONFIRM sites according to Society of Cardiovascular
Computed Tomography guidelines by level III-qualified readers and
the variety of sites included in the analysis ensures that our measures
are clinically useful across different institutions, CT platforms, post-
processing software, and independent of vendor. Second, the
administration of b-blockers is essential in cardiac CT imaging since
image quality is clearly improved at heart frequencies ,70 bpm.43
Since an influence of b-blocker administration on myocardial
contractility cannot be excluded in our study, the generalizability
of LV functional measurements obtained by cardiac CT to other im-
aging modalities might be limited. However, previous studies have
demonstrated high accuracy and a tight concordance of LVEF values
obtained by cardiac CT with those provided by CMR.44,45
In addition, our results correlate well with previously published
functional LV values for CMR and echocardiography.46,47 Third,
our results are based on a population that has been referred for
cardiac CT. Patients with diabetes, hypertension, structural heart
disease, and obstructive CAD were excluded, while patients with
non-obstructive (,50% luminal narrowing) CAD were included
in the analysis. This approach can be criticized since subjects
referred for cardiac CT may have some reasons for the referral,
which may not be found at the examination, indicating that they
may not be representative of a healthy reference population. In
addition, a previous meta-analysis in patients undergoing cardiac
CT suggests that patients with non-obstructive CAD confer a great-
er incidence of major adverse cardiac events when compared with
patients with entirely normal coronary arteries.48 Further, abnor-
malities in diastolic function have recently been observed in a
CMR study in women with non-obstructive CAD and symptoms
of ischaemia.49 However, in accordance with our data, in this recent
CMR study, LVEF and LV volumes were similar between patients
with non-obstructive CAD and normal coronary arteries, and given
the high prevalence of non-obstructive CAD in the elderly popula-
tion, applying very rigorous exclusion criteria may have led to a
reference population that represents a ‘too healthy’ part of the
population. Thus, we believe that the inclusion and exclusion criteria
in this study represent a reasonable balance in order to have a rele-
vant reference population reflecting the real word for establishing
normal limits.
In summary, in this large international multicentre study we
observed a significant increase in LV systolic function with
advancing age; these alterations are particularly pronounced in
women. Our findings indicate that the LV undergoes a continuous
lifelong remodelling and suggest that the risk of cardiovascular
events might start at higher LVEF indices in women, thereby
emphasizing the need for gender- and age-specific criteria in
clinical decision making. Given the prognostic importance of
LVEF, further studies will need to explore variables that modulate
myocardial contractility and, thus, vulnerability to cardiac injury in
aged individuals.
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